Pulmonx Co. (NASDAQ:LUNG) Receives $14.17 Consensus PT from Analysts
Pulmonx Co. (NASDAQ:LUNG – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages […]
More Stories
Stratos Investment Management LLC Buys 1,088 Shares of Honeywell International Inc. (NASDAQ:HON)
Stratos Investment Management LLC lifted its stake in shares of Honeywell International Inc. (NASDAQ:HON – Free Report) by 6.3% during...
Stratos Investment Management LLC Raises Position in Citigroup Inc. (NYSE:C)
Stratos Investment Management LLC lifted its stake in Citigroup Inc. (NYSE:C – Free Report) by 98.9% in the 3rd quarter,...
Direxion Auspice Broad Commodity Strategy ETF (NYSEARCA:COM) Shares Sold by Stratos Investment Management LLC
Stratos Investment Management LLC cut its stake in Direxion Auspice Broad Commodity Strategy ETF (NYSEARCA:COM – Free Report) by 17.8%...
NuScale Power Co. (NYSE:SMR) Insider Robert K. Temple Sells 115,866 Shares of Stock
NuScale Power Co. (NYSE:SMR – Get Free Report) insider Robert K. Temple sold 115,866 shares of the company’s stock in...
Crown (NYSE:CCK) Upgraded at StockNews.com
StockNews.com upgraded shares of Crown (NYSE:CCK – Free Report) from a hold rating to a buy rating in a research...
FB Financial (NYSE:FBK) Price Target Raised to $50.00
FB Financial (NYSE:FBK – Free Report) had its target price upped by Keefe, Bruyette & Woods from $48.00 to $50.00...